| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.9M | -36.4% |
| Cost of Revenue | $1.9M | -33.0% |
| Gross Profit | $1.0M | -41.9% |
| R&D Expense | $236K | +57.5% |
| SG&A Expense | $8.2M | +2.2% |
| Operating Income | -$12.7M | +71.0% |
| Pre-tax Income | -$12.7M | +71.0% |
| Income Tax | $0 | — |
| Net Income | -$12.7M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $457K | -83.5% |
| Short-term Investments | $0 | -100.0% |
| Accounts Receivable | $692K | -66.6% |
| Inventory | $6.8M | +20.4% |
| Current Assets | $12.1M | -34.3% |
| Total Assets | $22.7M | -32.3% |
| Current Liabilities | $1.8M | +20.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.2M | +42.9% |
| Capital Expenditures | $36K | -78.8% |
| Investing Cash Flow | $2.3M | -58.1% |
| Financing Cash Flow | -$430K | -174.7% |
| Free Cash Flow | -$4.3M | +43.7% |
| +71.0% |
| EPS (Basic) | -$0.84 | +71.2% |
| Long-term Debt |
| $280K |
| — |
| Total Liabilities | $2.0M | +35.7% |
| Stockholders' Equity | $20.6M | -35.5% |